Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction

被引：0
|
作者：
Wilson, MG
Jamal, HH
Wischet, W
Reid, P
机构：
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3552
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [21] Randomized COMparison of platelet inhibition with abciximab, TiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes - The COMPARE trial
    Batchelor, WB
    Tolleson, TR
    Huang, Y
    Larsen, RL
    Mantell, RM
    Dillard, P
    Davidian, M
    Zhang, DW
    Cantor, WJ
    Sketch, MH
    Ohman, EM
    Zidar, JP
    Gretler, D
    DiBattiste, PM
    Tcheng, JE
    Califf, RM
    Harrington, RA
    CIRCULATION, 2002, 106 (12) : 1470 - 1476
  • [22] Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction - The MULTISTRATEGY randomized trial
    Valgimigli, Marco
    Campo, Gianluca
    Percoco, Gianfranco
    Bolognese, Leonardo
    Vassanelli, Corrado
    Colangelo, Salvatore
    de Cesare, Nicoletta
    Rodriguez, Alfredo E.
    Ferrario, Maurizio
    Moreno, Raul
    Piva, Tommaso
    Sheiban, Imad
    Pasquetto, Giampaolo
    Prati, Francesco
    Nazzaro, Marco S.
    Parrinello, Giovanni
    Ferrari, Roberto
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15): : 1788 - 1799
  • [23] Commentary: A pile of vital cells is needed to treat myocardial infarction
    Mennander, Ari A.
    JTCVS OPEN, 2021, 8 : 377 - 378
  • [24] ASPIRIN TO PREVENT MYOCARDIAL-INFARCTION AND DEATH
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1986, 28 (709): : 31 - 32
  • [25] Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial
    Guaaliumi, Giulio
    Witzenbichler, Bernhard
    Peruga, Jan
    Brodle, Bruce
    Dudek, Danusz
    Kornowski, Ran
    Kochman, Janusz
    Almagor, Yaron
    Nilsen, Dennis
    Kirtane, Ajay
    Parise, Helen
    Mehran, Roxana
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B87 - B87
  • [26] Clinical outcomes comparing eptifibatide and abciximab in ST-elevation acute myocardial infarction patients undergoing percutaneous coronary intervention.
    Midei, MG
    Lowry, DR
    Coombs, V
    Loughrey, MB
    Gottlieb, SO
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A) : 240E - 241E
  • [27] A comparison of number needed to treat for selected therapies.
    Dimai, H
    Sieghart, S
    Klaushofer, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S535 - S535
  • [28] Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention
    Herrmann, HC
    Swierkosz, TA
    Kapoor, S
    Tardiff, DC
    DiBattiste, PM
    Hirshfeld, JW
    Klugherz, BD
    Kolansky, DM
    Magness, K
    Valettas, N
    Wilensky, RL
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (11) : 1293 - +
  • [29] Number of patients needed to treat to prevent death in genotype 1 chronic hepatitis C cirrhosis: the impact of improved interferon-based therapy
    van der Meer, Adriaan J.
    Veldt, Bart J.
    Feld, Jordan J.
    Wedemeyer, Heiner
    Dufour, Jean-Francois
    Lammert, Frank
    Duarte-Rojo, Andres
    Manns, Michael P.
    Zeuzem, Stefan
    Hofmann, Wolf P.
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2012, 56 : 270A - 271A
  • [30] The Message Is Clear Prevent as Well as Treat Acute Myocardial Infarction
    Cohn, Jay N.
    CIRCULATION, 2013, 128 (24) : 2554 - 2556
12345